Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Israel Biofund Gp Limited Partnership Orbimed currently holds 2,311,798 shares of Chemomab Therapeutics Ltd. (CMMB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Israel Biofund Gp Limited Partnership Orbimed has been a net seller of CMMB stock. They have purchased $2.1M and sold $22.1M worth of shares.
Israel Biofund Gp Limited Partnership Orbimed's most recent insider trade was on Jan 3, 2023, when they sold 266,376 shares at $3.34 per share.
Israel Biofund Gp Limited Partnership Orbimed serves as Executive at Chemomab Therapeutics Ltd. (CMMB). They have executed 15 insider transactions totaling $24.2M over their tenure at the company.
Israel Biofund Gp Limited Partnership Orbimed holds the position of Executive at Chemomab Therapeutics Ltd., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Israel Biofund Gp Limited Partnership Orbimed has shown a selling trading pattern, with $2.1M in total purchases and $22.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Israel Biofund Gp Limited Partnership Orbimed was on Jun 25, 2021, when they sold $19.3M worth of NMTR shares. This transaction involved 15,989,876 shares at $1.21 per share.
Israel Biofund Gp Limited Partnership Orbimed currently owns 2,311,798 shares of Chemomab Therapeutics Ltd. (CMMB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Israel Biofund Gp Limited Partnership Orbimed's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Israel Biofund Gp Limited Partnership Orbimed has 15 Form 4 filings on record as an insider at Chemomab Therapeutics Ltd..
Set alerts for Israel Biofund Gp Limited Partnership Orbimed and 40,000+ other insiders.